摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-chloro-6-methoxy-1,5-naphthyridine-3-carbonitrile | 872714-57-3

中文名称
——
中文别名
——
英文名称
4-chloro-6-methoxy-1,5-naphthyridine-3-carbonitrile
英文别名
4-Chloro-6-(methyloxy)-1,5-naphthyridine-3-carbonitrile
4-chloro-6-methoxy-1,5-naphthyridine-3-carbonitrile化学式
CAS
872714-57-3
化学式
C10H6ClN3O
mdl
——
分子量
219.63
InChiKey
PDLFBBIUMUHLAY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    373.9±37.0 °C(Predicted)
  • 密度:
    1.43±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    58.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS BICYCLIQUES PONTÉS POUR LE TRAITEMENT DES INFECTIONS BACTÉRIENNES
    申请人:KYORIN SEIYAKU KK
    公开号:WO2013003383A1
    公开(公告)日:2013-01-03
    Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.
    本文披露了新型桥环双环化合物,以及它们的药用盐、合物和前药。还披露了包含这些化合物的组合物,制备这些化合物的方法以及将这些化合物用作抗菌剂的方法。所披露的化合物、其药用盐、合物和前药,以及包含这些化合物、盐、合物和前药的组合物,可用于治疗细菌感染及相关疾病和症状。
  • Antibacterial Agents
    申请人:Miller Henry William
    公开号:US20070254872A1
    公开(公告)日:2007-11-01
    Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    本文披露了在哺乳动物,特别是人类的细菌感染治疗中有用的喹啉喹喔啉啶衍生物
  • Antibacterial agents
    申请人:Miller Henry William
    公开号:US20070161627A1
    公开(公告)日:2007-07-12
    Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    本文揭示了在哺乳动物,特别是人类中治疗细菌感染有用的喹啉喹硫平啶衍生物
  • BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
    申请人:Fukuda Yasumichi
    公开号:US20140243302A1
    公开(公告)日:2014-08-28
    Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.
    本文披露了新型桥环双环化合物及其药学上可接受的盐、合物和前药。还披露了包含这些化合物的组合物、制备这些化合物的方法以及将这些化合物用作抗菌剂的方法。披露的化合物、它们的药学上可接受的盐、合物和前药,以及包含这些化合物、盐、合物和前药的组合物,可用于治疗细菌感染及相关疾病和病情。
  • Antibacterial compounds having broad spectrum of activity
    申请人:AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A.
    公开号:US10221144B2
    公开(公告)日:2019-03-05
    The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.
    本发明涉及新型抗菌化合物、含有这些化合物的药物组合物及其作为抗菌剂的用途。
查看更多